Sporadic ovarian cancer: the probable model of pathogenesis
- Authors: Ashrafyan L.A1
-
Affiliations:
- Russian Scientific Center of Radiology
- Issue: Vol 61, No 4 (2012)
- Pages: 3-10
- Section: Articles
- URL: https://bakhtiniada.ru/jowd/article/view/1331
- DOI: https://doi.org/10.17816/JOWD6143-10
- ID: 1331
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Leo A Ashrafyan
Russian Scientific Center of Radiology
Email: levaa2004@yahoo.com
professor, MD, head of the gynecological department
References
- Аксель Е. М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология. — 2012. — № 1. — С. 18–23.
- Глазунов М. Ф. Опухоли яичников. — М.: Медгиз, 1954. — 324 с.
- Дорохов И. И. Мезотелий париетальной брюшины человека и изменения его при некоторых заболеваниях. — Л.,1951
- Рак женских репродуктивных органов в процессе эволюции / Итон С. Б. [и др.] // Вопр. онкол. — 1991. — № 9–10. — С. 899–907
- A case-control study of oral contraceptive use and invasive epithelial ovarian cancer / Rosenberg L. [et al.] // Am. J. Epidemiol. — 1994. — Vol. 139. — P. 654–661.
- A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma / Kowalski L. D. [et al.] // Cancer. — 1997. — Vol. 79. — P. 1587–1594.
- Altinoz M. A., Korkmaz R. NF-kappaB, mac- rophage migration inhibitory factor and cyclooxyge- naseinhibitions as likely mechanisms behind the acеtaminophen — and NSAID- prevention of the ovarian cancer // Neoplasma. — 2004. — Vol. 51. — P. 239–247.
- An epidemiologic case-control study of ovarian cancer and reproductive factors / Nanca P. C. [et al.] // Am. J. Epidemiol. — 1984. — Vol. 119. — P. 705–713.
- C-erbB-2 and p53 expression in fallopian tube carcinoma / Lacy M. Q. [et al.] // Cancer. — 1995. — Vol. 75. — P. 2891–2896.
- Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US control studies / Whittemore A. S. [et al.] // Am. J. Epidemiol. — 1992. — Vol. 136. — P. 1212–1220.
- Edmondson R. J., Monaghan J. M., Davies B. R. The human ovarian surface epithelium is an androgen responsive tissue // Br. J. Cancer. — 2002. — Vol. 86. — P. 879–885.
- Follicle stimulating hormone-induced growth promotion and gene ex pression profiles on ovarian surface epithelial cells / Ji Q. [et al.] // Int. J. Cancer. — 2004. — Vol. 112. — P. 803–814.
- Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis / Pere H. [et al.] // Cancer Res. — 1998. — Vol. 58. — P. 4274–4276.
- Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha (v)-integrin / Schiffenbauer Y. S. [et al.] // Gynecol. Oncol. — 2002. — Vol. 84. — P. 296–302.
- Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma / Halperin R. [et al.] // Int. J. Gynecol. Pathol. — 2001. — Vol. 20. — P. 341–345.
- Keller Th. L’activite normale et pathologique de l’epithelium germinatif de l’ovaire adalte // Gynecol. Obstet. — 1928. — Vol. 17. — P. 10–39.
- Maximov A. A. = Максимов А. А. Die hystologishen Vorgange bei der Heilung von Eierstocksverletzungen und die Regenerationsfahigkeit des Eiertockgewebes // Virch. Arch. — 1900. — S. 160.
- Molecular similarities between primary peritoneal and primary ovarian carcinomas / Chen L. M. [et al] // Int. J. Gynecol. Cancer. — 2003. — Vol. 13. — P. 749–755.
- Ness R. B., Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer // J. Natl. Cancer Inst. — 1999. — Vol. 91. — P. 1459–1467.
- NIH Consensus Development Conference Statement. Ovarian cancer: screening, treatment and Follow-up // Gynecol. Oncol. — 1994. — Vol. 55. — P. 4–14.
- Noara H. Developmental vpatterning in the wrong context: The paradox of epithelial ovarian cancers // Cell Cycle. — 2005. — Vol. 4. — P. 1033–1035.
- Ovarian cancer risk after the use of ovulation stimulating drugs / Brinton L. A. [et al] // Obstet. Gynecol. — 2004. — Vol. 103. — P. 1194–1203.
- Ovarian surface epithelium: biology, endocrinology and pathology / Auersperg N. [et al.] // Endocr. Rev. — 200. — Vol. 122. — P. 225–228.
- Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel / Gaspard U. J. [et al.] // Contraception. — 1983. — Vol. 27. — P. 577–590.
- Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer / Gwinn M. L. [et al.] // J. Clin. Epidemiol. — 1990. — Vol. 43. — P. 559–568.
- Pregnensy recency and risk of ovarian cancer / Cooper G. S. [et al.] // Cancer Caus. Contr. — 1999. — Vol. 10. — P. 397–402.
- Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer / Halperin R. [et al.] // Int. J. Gynecol. Cancer. — 2001. — Vol. 11. — P. 403–408.
- Purdie D. M., Bain C. J., Siskind V. Hormon replacement therapy and the risk of epithelial ovarian cancer // Br. J. Cancer. — 1999. — Vol. 81. — P. 559–564.
- Riman T., Persont N. S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence // Clin. Endocrinol. — 1998. — Vol. 49, N 6. — P. 695–707.
- Risch H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone // J. Natl. Cancer. Inst. — 1998. — Vol. 90. — P. 1774–1786.
- Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and independent growth in human ovarian surface epithelial cell lines / Tashiro H. [et al.] // Cancer Sci. — 2003. — Vol. 94. — P. 953–959.
- Seeger H., Wallwiener D., Mueck A. O. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? // Eur. J. Gynaecol. Oncol. –2006. — Vol. 27. — P. 139–141.
- Shafer Z. T., Brugge J. S. IL-6 involvement in epithelial cancer // J. Clin. Invest. — 2004. — Vol. 117, N 12. — P. 3660–3663.
- Stecca B., Mas C., Ruiz i Altaba A. Interference with HH-GLI signaling inhibits cancer // Trends Mol. Med. — 2005. — Vol. 11, N 5. — P. 199–203.
- Tumor inflammatory angiogenesis and its chemoprevation / Albini A. [et al.] // Cancer Res. — 2005. — Vol. 65, N 23. — P. 10637–10641
- VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors / Wang J. [et al.] // Int. J. Cancer. — 2002. — Vol. 97. — P. 163–167.
- Vessey M., Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004 // Br. J. Cancer. — 2006. — Vol. 95, N 3. — P. 385–389.
- Walthard M. Zur Aetiologieder Ovarialadenoma // Ztschr. Geburtsh. Gynak. — 1903. — Vol. 49. — S. 233–329.
Supplementary files
